Clinical Trials, Inc. (CTI)

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Epilepsy2 trials

Phase

• Phase 11 trial
• Phase 21 trial

Status

• Completed2 trials

Lead sponsor

• NeuroPro Therapeutics, Inc.2 trials

Closed trials

• Completed

  A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures

  NCT06769659· Phase 2· NeuroPro Therapeutics, Inc.· Source

• Completed

  A Double Blind, Randomized, Cross-over Study Examining the Suppression of the Photoparoxysmal EEG Response With NPT 2042

  NCT06525649· Phase 1· NeuroPro Therapeutics, Inc.· Source